Presentation by an expert: IL17 and the development of inflammatory airway diseases

J. Kolls (Pittsburgh, United States of America)

Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Number: 30
Disease area: Airway diseases

Slide presentationPDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Kolls (Pittsburgh, United States of America). Presentation by an expert: IL17 and the development of inflammatory airway diseases. Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Presentation by an expert: IL33 and onset of chronic lung disease
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013


Presentation by an expert: Role of basophils in allergic inflammation and protective immunity
Source: Lung Science Conference 2014 - Lung Inflammation and Immunity
Year: 2014

Neutrophils in chronic inflammatory airway diseases: can we target them and how?
Source: Eur Respir J 2010; 35: 467-469
Year: 2010


Pro-inflammatory cytokines in pathogenesis professional occupetional pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 148s
Year: 2004

Role of systemic inflammation mediated by IL-6 and TNF-alpha cytokines in chronic obstructive pulmonary disease and its progression: A three year follow up study
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013

Interleukin-33 and Th2 cytokines correlate in acute asthma
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016

Targeting TNF-alpha in inflammatory lung diseases
Source: Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes
Year: 2005


Systemic cytokine signaling via IL-17 and its relation to clinical characteristics in children with asthma
Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers
Year: 2015

Presentation by an expert: Impaired control of infection in the allergic lung microenvironment
Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease
Year: 2011



Presentation by an expert: Interactions between innate immunity, inflammation and structural cells in pulmonary disease
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013


Presentation by an expert: Early influences of the airway microbiome on obstructive lung disease
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013


Pathology, inflammation and cytokines of severe asthma
Source: Eur Respir Mon 2011; 51: 97-106
Year: 2011


Proinflammatory cytokines and IP-10 differentiate neutrophilic and eosinophilic asthma subgroups
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016

Assessment of anti-inflammatory cytokines in professional lung diseases
Source: Eur Respir J 2005; 26: Suppl. 49, 148s
Year: 2005

Rhinitis, nasal polyposis and asthma: pathological aspects
Source: ISSN=1025-448x, ISBN=1-904097-19-18, page=115
Year: 2001

Investigation of alarmins, interleukin (IL-)23 and IL-36 sputum levels in chronic airway obstructive diseases.
Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases
Year: 2019

Eosinophils as potential mediators of autoimmunity in eosinophilic lung disease
Source: Eur Respir Monogr 2022; 95: 219-237
Year: 2022


Expression of nasal and bronchial IL-17F and related cytokines in frequent exacerbators with neutrophilic severe asthma
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016